Quick Answer
CYTOKINETICS INC reported Research And Development Expense of $416.03 million for the year ending 2025.
- CYTOKINETICS INC showed an increase of +22.6% in Research And Development Expense from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), CYTOKINETICS INC's Research And Development Expense has grown by 944.2%.
- Historical annual values: Fiscal year 2025: $416.03 million | Fiscal year 2024: $339.41 million | Fiscal year 2023: $330.12 million | Fiscal year 2022: $240.81 million | Fiscal year 2021: $159.94 million | Fiscal year 2020: $96.95 million | Fiscal year 2019: $86.13 million | Fiscal year 2018: $89.14 million | Fiscal year 2017: $90.30 million | Fiscal year 2016: $59.90 million | Fiscal year 2015: $46.40 million | Fiscal year 2014: $44.43 million | Fiscal year 2013: $49.45 million | Fiscal year 2012: $35.64 million | Fiscal year 2011: $37.18 million | Fiscal year 2010: $38.01 million | Fiscal year 2009: $39.84 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: